Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs – a molecule that neutralizes the bugs’ ability to destroy the antibiotic.
Scientists at OSU were part of an international collaboration that demonstrated the molecule’s ability to inhibit expression of an enzyme that makes bacteria resistant to a wide range of penicillins.
The molecule is a PPMO, short for peptide-conjugated phosphorodiamidate morpholino oligomer. The enzyme it combats is known as New Delhi metallo-beta-lactamase, or NDM-1, and it’s accompanied by additional genes that encode resistance to most if not all antibiotics.
“We’re targeting a resistance mechanism that’s shared by a whole bunch of pathogens,” said Bruce Geller, professor of microbiology in OSU’s College of Science and College of Agricultural Sciences, who’s been researching molecular medicine for more than a decade. “It’s the same gene in different types of bacteria, so you only have to have one PPMO that’s effective for all of them, which is different than other PPMOs that are genus specific.”
The Oregon State study showed that in vitro the new PPMO restored the ability of an antibiotic — in this case meropenem, an ultra-broad-spectrum drug of the carbapenem class — to fight three different genera of bacteria that express NDM-1. The research also demonstrated that a combination of the PPMO and meropenem was effective in treating mice infected with a pathogenic strain of E. coli that is NDM-1 positive.
Results of the study, supported by a grant from the National Institutes of Health, were recently published in the Journal of Antimicrobial Chemotherapy.
Geller says the PPMO will likely be ready for testing in humans in about three years.
“We’ve lost the ability to use many of our mainstream antibiotics,” Geller said. “Everything’s resistant to them now. That’s left us to try to develop new drugs to stay one step ahead of the bacteria, but the more we look the more we don’t find anything new. So that’s left us with making modifications to existing antibiotics, but as soon as you make a chemical change, the bugs mutate and now they’re resistant to the new, chemically modified antibiotic.”
That progression, Geller explains, made the carbapenems, the most advanced penicillin-type antibiotic, the last line of defense against bacterial infection.
“The significance of NDM-1 is that it is destroys carbapenems, so doctors have had to pull out an antibiotic, colistin, that hadn’t been used in decades because it’s toxic to the kidneys,” Geller said. “That is literally the last antibiotic that can be used on an NDM-1-expressing organism, and we now have bacteria that are completely resistant to all known antibiotics. But a PPMO can restore susceptibility to antibiotics that have already been approved, so we can get a PPMO approved and then go back and use these antibiotics that had become useless.”
Receive an email update when we add a new ANTIBIOTIC RESISTANCE article.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Why COVID is just the tip of a terrifying, but potentially revolutionary, antibiotic resistant icebergon April 9, 2021 at 10:25 am
Notable bacteria are resistant to nearly all antibiotics and some have even become resistant to all forms of treatment. AMR occurs naturally, but the misuse and overuse of antibiotics in human ...
- Molecule could beat antibiotic-resistant infectionson April 8, 2021 at 7:08 am
By using their knowledge of how bacteria co-exist and compete with one another in nature, Western University researchers have discovered a compound that can inhibit the growth of Staphylococcus aureus ...
- Bacteria 'shuffle' their genetics around to develop antibiotic resistance on demandon April 7, 2021 at 4:28 am
In order to solve antibiotic resistance, one thing researchers first need to understand is how to stop resistance from happening to begin with. A recent study I conducted with colleagues at the ...
- Listen: Antibiotic experts on the threat of antimicrobial resistant superbugson April 7, 2021 at 4:10 am
This week’s “First Opinion Podcast” takes a look at antimicrobial resistance, a topic that should be worrying everyone, but isn’t. I talk with David Hyun and Rachel Zetts, both with The Pew Charitable ...
- Antibiotics can be taken for shorter periods, doctors' group sayson April 6, 2021 at 9:12 am
Millions of Americans have at some point in their lives gotten a long course of antibiotics to treat a bacterial infection.
- Scientists confirm bacteria’s genetic ‘Swiss army knife’ is key driver of antibiotic resistanceon April 6, 2021 at 6:17 am
Antibiotic resistance is a huge challenge facing society globally, posing a threat not only to human health but in areas such as food security and ...
- A crisis even bigger than Covid: the new war on antibiotic resistanceon April 4, 2021 at 9:00 am
After her transplant, with her immune system suppressed to prevent rejection of the new organs, Isabelle was even more reliant on the drugs. But infection did take hold. A strain of the bacteria ...
- Global Antibiotic Resistance Market Size, Share, Value, and Competitive Landscape 2024on April 1, 2021 at 9:10 pm
The MarketWatch News Department was not involved in the creation of this content. Apr 02, 2021 (Heraldkeepers) -- Antibiotic resistance happens when germs like bacteria and fungi develop the ability ...
- Antibiotic Resistance Professional Survey Global Market Growth, Status and Outlook Research Report 2021on April 1, 2021 at 3:23 am
Antibiotic resistance happens when germs like bacteria and fungi develop the ability to defeat the drugs designed to ...
via Bing News